Paolo Lissoni

7.4k total citations
289 papers, 5.7k citations indexed

About

Paolo Lissoni is a scholar working on Endocrine and Autonomic Systems, Oncology and Immunology. According to data from OpenAlex, Paolo Lissoni has authored 289 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Endocrine and Autonomic Systems, 91 papers in Oncology and 48 papers in Immunology. Recurrent topics in Paolo Lissoni's work include Circadian rhythm and melatonin (100 papers), Cancer Immunotherapy and Biomarkers (41 papers) and Cancer, Stress, Anesthesia, and Immune Response (40 papers). Paolo Lissoni is often cited by papers focused on Circadian rhythm and melatonin (100 papers), Cancer Immunotherapy and Biomarkers (41 papers) and Cancer, Stress, Anesthesia, and Immune Response (40 papers). Paolo Lissoni collaborates with scholars based in Italy, Switzerland and United States. Paolo Lissoni's co-authors include Gabriele Tancini, Sandro Barni, Franco Rovelli, Antonio Ardizzoia, F Brivio, Franco Paolorossi, Luca Fumagalli, Fabio Malugani, Georges J. M. Maestroni and Fernando Brivio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Paolo Lissoni

279 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Lissoni Italy 40 2.4k 1.3k 1.0k 963 819 289 5.7k
Günter K. Stalla Germany 60 935 0.4× 821 0.6× 2.5k 2.4× 1.3k 1.4× 712 0.9× 306 13.5k
Pierluigi Navarra Italy 43 690 0.3× 605 0.5× 1.9k 1.8× 947 1.0× 932 1.1× 246 6.6k
Georges J. M. Maestroni Switzerland 41 3.2k 1.3× 279 0.2× 808 0.8× 1.2k 1.2× 496 0.6× 89 5.3k
Carlos R. Plata‐Saláman United States 47 2.0k 0.8× 281 0.2× 1.2k 1.2× 1.6k 1.6× 737 0.9× 142 6.7k
Markus Schwaninger Germany 60 859 0.4× 599 0.4× 4.1k 4.0× 1.8k 1.9× 1.8k 2.2× 217 12.3k
Gianluigi Mazzoccoli Italy 39 1.6k 0.7× 358 0.3× 1.4k 1.4× 1.2k 1.2× 316 0.4× 186 4.4k
Stephan von Hörsten Germany 46 400 0.2× 1.2k 0.9× 2.0k 2.0× 864 0.9× 525 0.6× 192 6.8k
Lin Yuan China 43 1.7k 0.7× 363 0.3× 2.3k 2.3× 698 0.7× 492 0.6× 126 5.3k
José Rodrigo Spain 50 887 0.4× 296 0.2× 2.1k 2.0× 2.0k 2.1× 302 0.4× 154 8.1k
Andrzej Lewiñski Poland 34 839 0.3× 331 0.2× 1.0k 1.0× 774 0.8× 333 0.4× 522 5.8k

Countries citing papers authored by Paolo Lissoni

Since Specialization
Citations

This map shows the geographic impact of Paolo Lissoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Lissoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Lissoni more than expected).

Fields of papers citing papers by Paolo Lissoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Lissoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Lissoni. The network helps show where Paolo Lissoni may publish in the future.

Co-authorship network of co-authors of Paolo Lissoni

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Lissoni. A scholar is included among the top collaborators of Paolo Lissoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Lissoni. Paolo Lissoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Messina, Giusy, et al.. (2021). Sexual Imagination Potency (SIP) Test to Explore the Unconscious Sexual Life of Humans. 3(1). 1 indexed citations
2.
Lissoni, Paolo, et al.. (2020). COVID-19 Disease as an Acute Angiotensin 1-7 Deficiency: A Preliminary Phase 2 Study with Angiotensin 1-7 in Association with Melatonin and Cannabidiol in Symptomatic COVID19 -Infected Subjects. 3(2). 1 indexed citations
3.
4.
5.
6.
7.
Lissoni, Paolo, et al.. (2010). HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.. PubMed. 23(6). 987–9. 3 indexed citations
8.
Lissoni, Paolo, et al.. (2010). Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients. SHILAP Revista de lepidopterología. 10 indexed citations
9.
Lissoni, Paolo, et al.. (2010). Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients.. PubMed. 15(4). 225–8. 14 indexed citations
10.
Lissoni, Paolo, et al.. (2009). A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.. PubMed. 23(1). 171–5. 47 indexed citations
11.
Cerea, Giulio, Massimo Vaghi, A Ardizzoia, et al.. (2003). Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.. PubMed. 23(2C). 1951–4. 87 indexed citations
12.
Giani, Luisa, Sofia Meregalli, Massimo Vaghi, et al.. (2000). Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients. Urologia Internationalis. 64(1). 3–8. 29 indexed citations
13.
Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1999). Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. European Journal of Cancer. 35(12). 1688–1692. 208 indexed citations
14.
Lissoni, Paolo, F Brivio, Simonetta Viviani, & Luca Fumagalli. (1999). Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy?. PubMed. 13(2). 110–4. 5 indexed citations
15.
Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1998). Immunobiological effects of interleukin-2, interleukin-12 or interleukin-2 plus interleukin-12 in metastatic cancer patients. 14(1). 41–44. 1 indexed citations
16.
Lissoni, Paolo, Gabriele Tancini, Sandro Barni, et al.. (1997). Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Supportive Care in Cancer. 5(2). 126–129. 79 indexed citations
17.
Lissoni, Paolo, Antonio Ardizzoia, F Brivio, et al.. (1996). Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin. Supportive Care in Cancer. 4(4). 313–316. 19 indexed citations
18.
Lissoni, Paolo, Sandro Barni, Fernando Brivio, et al.. (1995). A Biological Study on the Efficacy of Low–Dose Subcutaneous lnterleukin–2 plus Melatonin in the Treatment of Cancer–Related Thrombocytopenia. Oncology. 52(5). 360–362. 26 indexed citations
19.
Tagliabue, M, Paolo Lissoni, Sandro Barni, et al.. (1989). A Radiologic Study by CT Scan of Pineal Size in Cancer Patients: Correlation to Melatonin Blood Levels. Tumori Journal. 75(3). 226–228. 2 indexed citations
20.
Barni, Sandro, et al.. (1987). Anal Squamous Cell Carcinoma Arising on Radio-Dermatitis Cured with Chemotherapy Alone: Case Report. Tumori Journal. 73(4). 423–424. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Günter K. Stalla Breakdown of academic impact, for papers by Pierluigi Navarra Breakdown of academic impact, for papers by Georges J. M. Maestroni Breakdown of academic impact, for papers by Carlos R. Plata‐Saláman Breakdown of academic impact, for papers by Markus Schwaninger Breakdown of academic impact, for papers by Gianluigi Mazzoccoli Breakdown of academic impact, for papers by Stephan von Hörsten Breakdown of academic impact, for papers by Lin Yuan Breakdown of academic impact, for papers by José Rodrigo Breakdown of academic impact, for papers by Andrzej Lewiñski
Rankless by CCL
2026